drugset / Trial / NCT01634360
Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations
NaSingle-groupOpen-labelTreatment
Summary
A 48-month open label multi-centered extension study to evaluate the long-term safety, tolerability and efficacy of E2007 in patients with Parkinson's Disease with "wearing off" motor fluctuations and "on" period Dyskinesias.
Timeline
- Start
- 2004-11
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perampanel | Small molecule | 1 mg | — |
| Subject | Perampanel | Small molecule | 2 mg | — |
| Subject | Perampanel | Small molecule | 3 mg | — |
| Subject | Perampanel | Small molecule | 4 mg | — |